The canonical Wnt/β-catenin signaling pathway, the COX-2 and peroxisome proliferator-activated receptor gamma (PPARγ) activities that operate in opposing manner have an impact on regulation of tumor growth, including GBM. The gene discussed is PTGS2; the disease is glioblastoma.